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and at 3-year follow-up. The MSCT data at baseline were used to estimate the luminal dimensions, plaque burden, and composition (3); reconstruct coronary anatomy; and perform blood flow simulation (1).
The studied vessels were divided into 3-mm subsegments, and the baseline MSCT-derived plaque characteristics and predominant ESS (defined as the minimum averaged ESS in an arc of 90 ) in each 3-mm subsegment were used to identify predictors associated with the changes in the luminal dimensions and atheroma burden and composition at follow-up (1).
We define as significant disease progression an increase >21.6% of the plaque area at follow-up. This 
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